Background: Full genome sequencing of influenza A viruses (IAV), including those that arise from annual influenza epidemics, is undertaken to determine if reassorting has occurred or if other pathogenic traits are present. Traditionally IAV sequencing has been biased toward the major surface glycoproteins haemagglutinin and neuraminidase, while the internal genes are often ignored. Despite the development of next generation sequencing (NGS), many laboratories are still reliant on conventional Sanger sequencing to sequence IAV. Objectives: To develop a minimal and robust set of primers for Sanger sequencing of the full genome of IAV currently circulating in humans. Study design: A set of 13 primer pairs was designed that enabled amplification of the six internal genes of multiple human IAV subtypes including the recent avian influenza A(H7N9) virus from China. Specific primers were designed to amplify the HA and NA genes of each IAV subtype of interest. Each of the primers also incorporated a binding site at its 5 -end for either a forward or reverse M13 primer, such that only two M13 primers were required for all subsequent sequencing reactions. Results: This minimal set of primers was suitable for sequencing the six internal genes of all currently circulating human seasonal influenza A subtypes as well as the avian A(H7N9) viruses that have infected humans in China. Conclusions: This streamlined Sanger sequencing protocol could be used to generate full genome sequence data more rapidly and easily than existing influenza genome sequencing protocols.
Background
Influenza viruses belong to the family of Orthomyxoviridae RNA viruses. Influenza A viruses (IAV) contain eight segmented negative strand RNAs of approximately 13.5 kb which encode at least 12 proteins, including polymerase basic protein 2 (PB2) and 1 (PB1), PB1-F2, polymerase acidic protein (PA) and PA-X, hemagglutinin (HA), nucleoprotein (NP), neuraminidase (NA), matrix protein 1 and 2 (M1 and M2), and non-structural protein 1 and 2 (NS1 and NS2) [1] . There are 18 types of HA and 11 types of NA [2] [3] [4] [5] , and the combination of HA and NA subtypes provides the basis for IAV subtype classification (such as H1N1 and H3N2). Most of the subtypes are found in avian, some in swine, human and other species such as bats. While H1N1 and H3N2 are the most common subtypes currently circulating in humans [6] , there have also been sporadic cases of human infection with other influenza A subtypes in recent years [7] , such as H5N1,H7N9, H10N7, H7N9 and H9N2, H6N1 [8] [9] [10] [11] [12] [13] [14] [15] .
Both the HA and NA genes of influenza A, particularly those present in the currently circulating human H1N1 and H3N2 viruses continually evolve due to immune pressure from previous infections, leading to antigenic drift in the virus. In contrast, the six internal genes are relatively stable, although genetic reassortment among different virus subtypes can occur within avian and swine hosts, and less frequently in the humans. From time to time, some of these reassortant IAV viruses from animal sources may develop an ability to infect humans, such as was seen with the 2009 pandemic H1N1 virus, which appears to have been a swine reassortant virus [16] . Full genome sequencing of IAV is the standard way to identify the origin of a newly reassortant virus and it is also a powerful tool to help elucidate the molecular characteristics of the virus such as host range, replication efficiency, transmissibility and virulence [17] [18] [19] [20] .
There are two main technologies that are currently in use for influenza full genome sequencing, namely the next generation sequencing (NGS) and traditional Sanger sequencing. The entire genome sequences regardless of the subtypes can be amplified using universal IAV primers, and then sequenced using NGS [21] [22] [23] , however, the cost and availability of NGS equipment, coupled with the need for complicated bioinformatics analysis, are major barriers for many laboratories to introduce this new technology. Therefore, Sanger sequencing is still widely used in most of the laboratories involved in influenza surveillance and research.
Objectives
To develop a simple Sanger sequencing method that is able to amplify and sequence the full genomes of multiple circulating seasonal human IAV subtypes using the minimum number of primers.
Study design

Primer design
Sequence data for all eight genes of A(H3N2), A(H1N1), A(H1N1pdm09) were downloaded from the global initiative on sharing avian influenza data (GISAID) website, alignment of individual genes was done in Geneious 5.1 (Biomatters Ltd-New Zealand). HA and NA primers were designed specific for each IAV subtype unless otherwise stated. Primers for the internal gene segments were designed at a minimum to cover all known IVAs belonging to the seasonal H1N1, H3N2 and H1N1pdm09. All genes except the Matrix gene and NS gene (where only single sets of primers were used) were amplified with 2-3 overlapping PCR segments to ensure that good quality sequence data could be obtained from both directions in one segment, all primers were each tagged with either M13F or M13R universal sequencing primer at the 5 end, so that only two primers (M13F and M13R) were needed for sequencing all the PCR products ( Fig. 1 ). Altogether, 17 pairs of primers were needed to amplify the whole influenza A genome of each subtype of IAVs, of which 13 pairs were universal primers that could amplify the six internal gene segments of all known IAVs currently circulating in humans ( Table 1 ). Some of the primers were used were those recommended by the US CDC (Atlanta, Georgia) protocol as indicated in Table 1 .
Virus samples
Samples were received at the WHO Collaborating Centre for Reference and Research on Influenza, Melbourne as either IAV isolates in Madin-Darby canine kidney (MDCK ATCC CCL-34) cells or original respiratory clinical specimens (e.g. nasal swabs, throat swabs, nasal aspirates, nasopharyngeal swabs) from WHO National Influenza Centres, and other regional laboratories and hospitals in Australia, New Zealand, and the Asia/Pacific regions. If required virus samples were cultured in MDCK cells or embryonated hens eggs as previously described [24, 25] .
RNA extraction and RT-PCR
RNA was extracted from 140 l of a virus culture or an original specimen using QIAamp Viral RNA Mini Kit (Qiagen) according to the manufacturer's instruction.
cDNA was made from each RNA sample using ThermoScript RT-PCR System for First-Strand cDNA Synthesis (Invitrogen), with Uni12 primer [26] , then 2 l of the cDNA was amplified in a 50 l volume using the Platinum Taq DNA High Fidelity Polymerase kit (Invitrogen) containing specific gene primers as shown in Table 1 according to the manufacturer's instructions.
Sequencing and sequence analysis
RT-PCR products were purified by ExoSAP-IT (GE Healthcare), and then subjected to sequencing reactions using either M13F or M13R primer with Big Dye Terminator Reaction Mix (Applied Biosystems). The reaction products were purified by Big Dye XTerminator Purification Kit (Applied Biosystems) and run on ABI 3500 XL sequencer. Sequencing results were analysed using the DNAS-TAR Lasergene 9 package.
Results
Validation of IAV internal primers
A total of 13 pairs of primers were designed for the six internal gene segments (PB1, PB2, PA, NP, M, NS) of IAV as described in Methods and Materials. These primers were tested on 25 seasonal H1N1, 120H3N2, 130H1N1pdm09 and 10 influenza B MDCK grown viruses, with sample dates from 1980 to 2014. The represented viruses sequenced are listed in Table 2 . When tested on these viruses the primers were able to produce distinct PCR products that could be easily sequenced, and they also performed at a similar efficiency when tested on the different influenza A subtypes tested (H1N1, H1N1pdm09 and H3N2), with no cross reactivity against influenza B viruses. The analytical sensitivity was also determined on cDNA derived from serially diluted RNA samples, and similar levels in the limit of detection (LOD) were found for respective gene segments of various subtypes, ranging from 50 to 50,000 copies/reaction (data not shown). The LOD for NS and NP genes were the most sensitive (50 copies/reaction), whereas some polymerase fragments had a lower sensitivity (50,000 copies/reaction).
Specificity and sensitivity of HA and NA primers
The subtype specific HA and NA primers were tested for specificity on over 200 seasonal H1N1 viruses (sample dates from 1934 to 2009), 1500H3N2 viruses (sample dates 1976-2014) and 1500H1N1pdm09 viruses (sample dates 2009-2014). All the primers tested were specific for the HA and NA genes of their corresponding subtypes, with no cross-reaction to the other IAV subtypes or influenza B virus. The LOD on HA and NA for all subtypes were found in the range of 500-5000 copies/reaction.
Evaluation of IAV internal gene primers for amplification of other subtypes
All the internal primers were further tested on a number of influenza A subtypes discovered either in humans or animals. Results revealed that they were able to amplify the internal genes of all selected influenza A viruses including H2N2 (A/Singapore/1/1957), H10N7 (A/Chicken/Queensland/1/2012), H1N2 (A/Brisbane/116/2002 and A/Sydney/12/2003), and the avian H7N9 virus (A/Anhui/1/2013) ( Table 2) . When these primers were tested on selected H9N2 and H5N1 viruses, only the whole NP, NS and MP genes, but not the three polymerase genes, could be amplified successfully. Analysis of the polymerase genes of these subtypes revealed a high degree of diversity, making it difficult to design primers that also covered both H5N1 and H9N2 polymerase genes. 
Sequencing and sequence analysis of PCR products
All the PCR products generated from various subtypes were sequenced using M13F and M13R primers. High quality sequence data were generated which was reflected by a long contiguous read length (CRL) (up to 900 bp), and a high Phred quality value (QV20+ for over 99% of the bases). The sequence data derived from both ends using the two M13 primers effectively covered the whole fragment for all the PCR products, alleviating the need for further gap sequencing using additional internal primers. The assembled sequences were blasted against the sequence data available in Gen-Bank. Results revealed that all the sequenced IAVs belonged to their corresponding genes/subtypes and exhibited a high degree of homologies to the viruses sequenced from around the same time period.
Sequencing of IAV from original specimens
Further tests were performed to determine whether this set of PCR primers could efficiently amplify IAV genes from original specimens including nasal swabs and nasopharyngeal aspirates collected from patients. A total of 222 original specimens confirmed previously by real-time RT-PCR to carry various subtypes of IAVs were used for HA/NA PCR and sequencing. Among them, 12 contained the seasonal H1N1, 120H1N1pdm09, and 90H3N2 viruses, with a real-time Ct value on IAV matrix gene ranging from 16 to 33. Full HA and NA genes were successfully sequenced from more than 90% of the samples. Most of the samples that could not be amplified for one or more fragments of HA and/or NA had a high Ct value (>33), except for a few with a lower Ct value which most likely contained degraded RNA. Twelve of the original specimens (two containing H3N2 and 10H1N1pdm09) were chosen for full genome sequencing. All 12 samples had a Ct value on IAV matrix gene between 17 and 27. Results revealed that sequencing the full length of all eight genes was achieved with all of the 12 original samples.
Discussion
Full genome sequencing of IAV has been increasingly used for research and global surveillance of influenza viruses. Traditionally, this has been done by Sanger sequencing; however, the most critical determinant for a successful full genome Sanger sequencing strategy of IAV is the availability of primers that are able to target only the IAV sequences reliably but not the sequences of host genes or other pathogens. Due to the high diversity of IAVs, most of the Sanger-based methods developed to date are IAV subtype specific and often require the use of large numbers of primers. For example, the method reported by Lee et al [27] is applicable only to H3N2 subtype viruses, and it involves the use of 19 pairs of PCR primers for full genome amplification of the viruses, followed by an Table 2 Representatives of viruses from different subtypes of IAV being sequenced using the IAV internal primers.
Subtype
Virus designation Year Isolate type Virus host GISAID Isolate ID Genes sequenced additional 40 primers for sequencing the PCR products. Similarly, 198 primer sets were used initially to amplify and sequence the full genome of the first novel avian A(H7N9) virus that arose in China in 2013 which has now resulted in hundreds of human infections and many deaths [10] .
In this study, we demonstrated that using a set of only 13 pairs of primers we successfully amplified and sequenced all of the six internal gene segments from multiple IAV subtypes. Although these primers were mainly designed to sequence the circulating human IAV subtypes, they could also be used to sequence a limited number of other IAV subtypes from human and animal sources. For example, this set of primers successfully amplified and sequenced the full internal genes from H2N2, H10N7 and H1N2 viruses as well as the recently emerged avian H7N9 virus from China. Due to the high diversity of other IAVs, however, we found it very difficult, if not impossible to design a set of primers that could universally amplify the six internal genes from all influenza A subtypes.
In contrast to the six internal genes, the genes for HA and NA are notorious for their high heterogeneity which makes it impossible to design a set of primers that are applicable to the HA and NA genes of all subtypes. Therefore, in this study, the HA and NA genes of only three IAV subtypes were chosen as the targets for full genome sequencing because of their presence in the general human population in recent years. The primers designed were evaluated extensively for their subtype specificities on over 3200 cultured IAVs of different subtypes including H1N1, H3N2 and H1N1pdm09 viruses. The results demonstrated that the HA-and NA-specific primers could be applied to a wide range of viruses isolated from 1934 to the present time, and that no cross-reactivity between different IAV subtypes or to influenza B virus was detected with any of the primers tested. Most importantly, all the primers reported in this study did not cross react with other pathogens or host genes. In addition, the use of a single pair of M13 primers for all sequencing reactions not only simplifies the sequencing procedure but also ensures the generation of high quality sequences consistently.
With our simple and streamlined full genome Sanger sequencing protocol, up to five viruses can be sequenced overnight with just two 96-well sequencing plates on ABI 3500XL sequencer. The sequence data can be analysed using many standard programs quickly, leading to a much shorter turnaround times than are usually seen with NGS, especially in the case when only a small number of viruses are sequenced. Given the sensitivity of the primer pairs these assays could be used on both cell culture-derived and egg-grown virus isolates, as well as on clinical respiratory specimens when there is sufficient virus present. In conclusion, this simple Sanger sequencing protocol provides a useful backup sequencing strategy in this current era of NGS, and also enables smaller laboratories that do not have NGS equipment to use this Sanger sequencing method to rapidly and reliably sequence the circulating human IAV genomes from their regions.
